Cargando…

Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens

The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). The study subjects were 4876 workers aged from 40 to 61 years old. Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Yasushi, Tashiro, Hiromi, Kawamoto, Toshihiro, Kodama, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920667/
https://www.ncbi.nlm.nih.gov/pubmed/8636012
http://dx.doi.org/10.1111/j.1349-7006.1995.tb03317.x
_version_ 1783317870241906688
author Hattori, Yasushi
Tashiro, Hiromi
Kawamoto, Toshihiro
Kodama, Yasushi
author_facet Hattori, Yasushi
Tashiro, Hiromi
Kawamoto, Toshihiro
Kodama, Yasushi
author_sort Hattori, Yasushi
collection PubMed
description The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). The study subjects were 4876 workers aged from 40 to 61 years old. Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measured at the same time. PG I < 50 ng/ml and PG I/PG II ratio < 3.0 were adopted as the criteria for a positive result for the PG test. PG test‐positive subjects were examined, in principle, by endoscopy. Furthermore, all the subjects were followed up for a year to check for occurrence of gastric cancer. Among the total subjects, 911 (18.7%) were positive for the PG test and 650 (71.4%) among the positive subjects underwent further examinations, which revealed 11 cases of gastric cancer. Seven gastric cancer cases were diagnosed during the follow‐up period within one year after the PG test. Six out of the 7 cancer cases had been negative in the PG test. When the results of one year's follow‐up from the time of screening were defined as the gold standard, the sensitivity and specificity of the PG test were estimated at 66.7% and 81.5%, respectively. The authors conclude that the validity of the PG test as a mass screening method may be comparable to that of X‐ray screening, if optimum criteria of a positive test are selected.
format Online
Article
Text
id pubmed-5920667
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59206672018-05-11 Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens Hattori, Yasushi Tashiro, Hiromi Kawamoto, Toshihiro Kodama, Yasushi Jpn J Cancer Res Article The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). The study subjects were 4876 workers aged from 40 to 61 years old. Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measured at the same time. PG I < 50 ng/ml and PG I/PG II ratio < 3.0 were adopted as the criteria for a positive result for the PG test. PG test‐positive subjects were examined, in principle, by endoscopy. Furthermore, all the subjects were followed up for a year to check for occurrence of gastric cancer. Among the total subjects, 911 (18.7%) were positive for the PG test and 650 (71.4%) among the positive subjects underwent further examinations, which revealed 11 cases of gastric cancer. Seven gastric cancer cases were diagnosed during the follow‐up period within one year after the PG test. Six out of the 7 cancer cases had been negative in the PG test. When the results of one year's follow‐up from the time of screening were defined as the gold standard, the sensitivity and specificity of the PG test were estimated at 66.7% and 81.5%, respectively. The authors conclude that the validity of the PG test as a mass screening method may be comparable to that of X‐ray screening, if optimum criteria of a positive test are selected. Blackwell Publishing Ltd 1995-12 /pmc/articles/PMC5920667/ /pubmed/8636012 http://dx.doi.org/10.1111/j.1349-7006.1995.tb03317.x Text en
spellingShingle Article
Hattori, Yasushi
Tashiro, Hiromi
Kawamoto, Toshihiro
Kodama, Yasushi
Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
title Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
title_full Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
title_fullStr Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
title_full_unstemmed Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
title_short Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
title_sort sensitivity and specificity of mass screening for gastric cancer using the measurement of serum pepsinogens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920667/
https://www.ncbi.nlm.nih.gov/pubmed/8636012
http://dx.doi.org/10.1111/j.1349-7006.1995.tb03317.x
work_keys_str_mv AT hattoriyasushi sensitivityandspecificityofmassscreeningforgastriccancerusingthemeasurementofserumpepsinogens
AT tashirohiromi sensitivityandspecificityofmassscreeningforgastriccancerusingthemeasurementofserumpepsinogens
AT kawamototoshihiro sensitivityandspecificityofmassscreeningforgastriccancerusingthemeasurementofserumpepsinogens
AT kodamayasushi sensitivityandspecificityofmassscreeningforgastriccancerusingthemeasurementofserumpepsinogens